PepGen Inc
General ticker "PEPG" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $162.6M
PepGen Inc does not follow the US Stock Market performance with the rate: -12.1%.
Estimated limits based on current volatility of 7.4%: low 3.64$, high 4.22$
Factors to consider:
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.21$, 9.00$]
- 2024-12-30 to 2025-12-30 estimated range: [2.94$, 8.07$]
Short-term PEPG quotes
Long-term PEPG plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $27.11MM | $68.30MM | $84.77MM |
| Operating Income | $-27.11MM | $-68.30MM | $-84.77MM |
| Non-Operating Income | $-0.17MM | $2.90MM | $6.21MM |
| R&D Expense | $19.00MM | $54.08MM | $68.13MM |
| Income(Loss) | $-27.28MM | $-65.40MM | $-78.55MM |
| Taxes | $0.00MM | $3.71MM | $0.07MM |
| Profit(Loss) | $-27.28MM | $-69.10MM | $-78.63MM |
| Stockholders Equity | $-32.08MM | $179.63MM | $108.42MM |
| Assets | $143.64MM | $217.44MM | $143.05MM |
| Operating Cash Flow | $-22.60MM | $-59.27MM | $-69.00MM |
| Capital expenditure | $0.50MM | $3.75MM | $2.60MM |
| Investing Cash Flow | $-0.50MM | $-3.75MM | $-32.00MM |
| Financing Cash Flow | $147.66MM | $112.19MM | $-0.19MM |
| Earnings Per Share* | $-1.22 | $-2.91 | $-3.30 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.